Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Current Pharmaceutical Biotechnology
|
January 5, 2002
Future approaches for treating hematologic disease
M Reff, G Braslawsky, N Hanna
International Journal of Cancer
|
July 15, 1976
Tumor bound immunoglobulins: the relationship between the in vivo coating of tumor cells by potentially cytotoxic anti-tumor antibodies, and the expression of immune complex receptors
G Braslawsky, M Ran, I P Witz
Cancer Research
|
August 15, 1995
The induction of cytotoxic T cells and tumor regression by soluble antigen formulation
K Hariharan, G Braslawsky, A Black, et al.
Journal of Leukocyte Biology
|
December 1, 1993
Granulocyte-macrophage colony-stimulating factor plays a role in the functional activity of mast cells
R Meade, K M Neddermann, R S Greenfield, et al.
Journal of the National Cancer Institute
|
January 1, 1975
Intramitochondrial bodies in a human cell line carrying oncornavirus-like particles
J Keydar, G Braslawsky, T Dajbog, et al.
International Journal of Oncology
|
June 4, 1998
Tumor regression in mice following vaccination with human papillomavirus E7 recombinant protein in PROVAX
K Hariharan, G Braslawsky, R S Barnett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 31, 1998
Enhancement of cell-mediated immunity in melanoma patients immunized with murine anti-idiotypic monoclonal antibodies (MELIMMUNE) that mimic the high molecular weight proteoglycan antigen
M W Pride, S Shuey, A Grillo-Lopez, et al.
Clinical Immunology (Orlando, Fla.)
|
February 13, 2001
Modification of the Fc region of a primatized IgG antibody to human CD4 retains its ability to modulate CD4 receptors but does not deplete CD4(+) T cells in chimpanzees
R Newman, K Hariharan, M Reff, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Current Pharmaceutical Biotechnology
|
January 5, 2002
Future approaches for treating hematologic disease
M Reff, G Braslawsky, N Hanna
International Journal of Cancer
|
July 15, 1976
Tumor bound immunoglobulins: the relationship between the in vivo coating of tumor cells by potentially cytotoxic anti-tumor antibodies, and the expression of immune complex receptors
G Braslawsky, M Ran, I P Witz
Cancer Research
|
August 15, 1995
The induction of cytotoxic T cells and tumor regression by soluble antigen formulation
K Hariharan, G Braslawsky, A Black, et al.
Journal of Leukocyte Biology
|
December 1, 1993
Granulocyte-macrophage colony-stimulating factor plays a role in the functional activity of mast cells
R Meade, K M Neddermann, R S Greenfield, et al.
Journal of the National Cancer Institute
|
January 1, 1975
Intramitochondrial bodies in a human cell line carrying oncornavirus-like particles
J Keydar, G Braslawsky, T Dajbog, et al.
International Journal of Oncology
|
June 4, 1998
Tumor regression in mice following vaccination with human papillomavirus E7 recombinant protein in PROVAX
K Hariharan, G Braslawsky, R S Barnett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 31, 1998
Enhancement of cell-mediated immunity in melanoma patients immunized with murine anti-idiotypic monoclonal antibodies (MELIMMUNE) that mimic the high molecular weight proteoglycan antigen
M W Pride, S Shuey, A Grillo-Lopez, et al.
Clinical Immunology (Orlando, Fla.)
|
February 13, 2001
Modification of the Fc region of a primatized IgG antibody to human CD4 retains its ability to modulate CD4 receptors but does not deplete CD4(+) T cells in chimpanzees
R Newman, K Hariharan, M Reff, et al.
Page
of 1